ASC
GILD icon

Atalanta Sosnoff Capital’s Gilead Sciences GILD Stock Holding History

Atalanta Sosnoff Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
2,548
-313
-11% -$41.2K 0.01% 96
2026
Q1 		$399K Sell
2,861
-21
-0.7% -$2.94K 0.01% 89
2025
Q4 		$354K Sell
2,882
-117
-4% -$14.2K 0.01% 86
2025
Q3 		$333K Hold
2,999
– – 0.01% 89
2025
Q2 		$332K Buy
2,999
+78
+3% +$8.3K 0.01% 87
2025
Q1 		$327K Buy
2,921
+273
+10% +$28.2K 0.01% 90
2024
Q4 		$245K Buy
2,648
+119
+5% +$10.7K 0.01% 92
2024
Q3 		$212K Buy
+2,529
New +$193K ﹤0.01% 103
2024
Q1 		– Sell
-3,287
Closed -$266K – 106
2023
Q4 		$266K Buy
+3,287
New +$256K 0.01% 89
2019
Q1 		– Sell
-379,219
Closed -$23.7M – 92
2018
Q4 		$23.7M Sell
379,219
-35,508
-9% -$2.48M 0.86% 48
2018
Q3 		$32M Buy
+414,727
New +$31.3M 0.96% 44
2016
Q2 		– Sell
-45,987
Closed -$4.22M – 110
2016
Q1 		$4.22M Sell
45,987
-529,114
-92% -$47.7M 0.13% 78
2015
Q4 		$58.2M Sell
575,101
-155,406
-21% -$16.2M 1.73% 24
2015
Q3 		$71.7M Sell
730,507
-16,363
-2% -$1.82M 2.29% 15
2015
Q2 		$87.4M Sell
746,870
-4,202
-0.6% -$459K 2.4% 13
2015
Q1 		$73.7M Sell
751,072
-65,966
-8% -$6.7M 1.96% 22
2014
Q4 		$77M Sell
817,038
-390,234
-32% -$40.4M 1.9% 18
2014
Q3 		$129M Sell
1,207,272
-123,211
-9% -$12.1M 3.18% 6
2014
Q2 		$110M Sell
1,330,483
-357,151
-21% -$27.8M 2.41% 17
2014
Q1 		$120M Sell
1,687,634
-33,593
-2% -$2.63M 2.67% 13
2013
Q4 		$129M Buy
1,721,227
+173,023
+11% +$12M 2.79% 8
2013
Q3 		$97.3M Sell
1,548,204
-260,262
-14% -$15.6M 2.57% 12
2013
Q2 		$92.7M Buy
+1,808,466
New +$94.3M 2.25% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atalanta Sosnoff Capital's GILD Position: Q2 2026 in Review

Atalanta Sosnoff Capital reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $41.2K and leaving 2,548 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #96.

Atalanta Sosnoff Capital first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $129M in Q4 2013. 2,261 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Atalanta Sosnoff Capital held 2,548 shares of Gilead Sciences worth $322K as of Q2 2026.
  • Atalanta Sosnoff Capital sold 313 Gilead Sciences shares in Q2 2026, an estimated $41.2K.
  • Gilead Sciences made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #96 holding.
  • Atalanta Sosnoff Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • Atalanta Sosnoff Capital's Gilead Sciences position peaked at $129M in Q4 2013.
  • 2,261 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.